National Cancer Institute Home at the National Institutes of Health |

Cancer Intervention and Surveillance Modeling Network

Modeling to guide public health research and priorities

Prostate Cancer Modeling

The CISNET prostate group grew from a single team in 2000, to two teams in 2002, to three teams in 2005. The group’s interests include the natural history of the disease and its potential implications for the efficacy of the prostate-specific antigen (PSA) screening test, screening policy, overdiagnosis, novel prostate cancer biomarkers, patterns and outcomes of prostate cancer care, and health disparities in prostate cancer screening and treatment. The group has focused on modeling prostate cancer progression, screening, and treatment in the U.S. population, assuming biologically plausible assumptions validated against various data sources.

Research Highlights

CISNET Model Registry